|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits with banks | ||||||||||||||||||||
| Fed funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available for sale, at fair value (net of allowance for credit losses of $0) | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Loans receivable (net of allowance for credit losses 2023: $18,968; 2022: $16,999) | ||||||||||||||||||||
| Total loans receivable | ||||||||||||||||||||
| Loans receivable (net of allowance for credit losses of $25,632 and $19,882) | ||||||||||||||||||||
| Regulatory stock, at cost | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Foreclosed real estate owned | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest bearing demand | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Money market deposit accounts | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, $0.10 par value per share, authorized: 20,000,000 shares, issued: 2026: 11,183,140 shares, 2025: 9,516,503 shares | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock at cost: 2026: 290,841 shares; 2025: 222,645 shares | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
